82 FR 145 pgs. 35547-35548 - Importer of Controlled Substances Application: Sigma-Aldrich International GMBH

Type: NOTICEVolume: 82Number: 145Pages: 35547 - 35548
Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2017-16059 Filed 7-28-17; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version:  PDF Version
Pages: 35547, 35548

[top] page 35547

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Importer of Controlled Substances Application: Sigma-Aldrich International GMBH

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007).

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division ("Assistant Administrator") pursuant to section 7 of 28 CFR part 0, appendix of subpart R.

In accordance with 21 CFR 1301.34(a), this is notice that on January 19, 2016, Sigma-Aldrich International GMBH, Sigma Aldrich Co. LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118 applied to be registered as an importer of the following basic classes of controlled substances:

page 35548


[top] 
Controlled substance Drug code Schedule
Cathinone 1235 I
Methcathinone 1237 I
Mephedrone (4-Methyl-N-methylcathinone) 1248 I
N-Ethylamphetamine 1475 I
Aminorex 1585 I
Gamma Hydroxybutyric Acid 2010 I
Methaqualone 2565 I
Alpha-ethyltryptamine 7249 I
Ibogaine 7260 I
Lysergic acid diethylamide 7315 I
Marihuana 7360 I
Tetrahydrocannabinols 7370 I
Mescaline 7381 I
4-Bromo-2,5-dimethoxyamphetamine 7391 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
4-Methyl-2,5-dimethoxyamphetamine 7395 I
2,5-Dimethoxyamphetamine 7396 I
3,4-Methylenedioxyamphetamine 7400 I
N-Hydroxy-3,4-methylenedioxyamphetamine 7402 I
3,4-Methylenedioxy-N-ethylamphetamine 7404 I
3,4-Methylenedioxymethamphetamine 7405 I
4-Methoxyamphetamine 7411 I
Bufotenine 7433 I
Diethyltryptamine 7434 I
Dimethyltryptamine 7435 I
Psilocybin 7437 I
Psilocyn 7438 I
1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I
N-Benzylpiperazine 7493 I
MDPV (3,4-Methylenedioxypyrovalerone) 7535 I
Butylone 7541 I
Heroin 9200 I
Normorphine 9313 I
Etonitazene 9624 I
Amobarbital 2125 II
Pentobarbital 2270 II
Secobarbital 2315 II
Glutethimide 2550 II
Nabilone 7379 II
Phencyclidine 7471 II
Diphenoxylate 9170 II
Ecgonine 9180 II
Ethylmorphine 9190 II
Levorphanol 9220 II
Meperidine 9230 II
Thebaine 9333 II
Opium, powdered 9639 II
Levo-alphacetylmethadol 9648 II


The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis.

Dated: July 24, 2017.

Demetra Ashley,

Acting Assistant Administrator.

[FR Doc. 2017-16059 Filed 7-28-17; 8:45 am]

BILLING CODE 4410-09-P